2018. A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS. Brazilian Journal of Pharmaceutical Sciences. 54, 2 (Jul. 2018), e17163. DOI:https://doi.org/10.1590/s2175-97902018000217163.